1. Home
  2. AQMS vs ANEB Comparison

AQMS vs ANEB Comparison

Compare AQMS & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aqua Metals Inc.

AQMS

Aqua Metals Inc.

N/A

Current Price

$5.06

Market Cap

20.9M

Sector

Industrials

ML Signal

N/A

Logo Anebulo Pharmaceuticals Inc.

ANEB

Anebulo Pharmaceuticals Inc.

N/A

Current Price

$0.43

Market Cap

19.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AQMS
ANEB
Founded
2014
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.9M
19.4M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
AQMS
ANEB
Price
$5.06
$0.43
Analyst Decision
Buy
Hold
Analyst Count
1
1
Target Price
$12.00
N/A
AVG Volume (30 Days)
82.2K
78.7K
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
21.88
EPS
N/A
N/A
Revenue
$2,100,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$550.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$0.41
52 Week High
$39.37
$3.42

Technical Indicators

Market Signals
Indicator
AQMS
ANEB
Relative Strength Index (RSI) 43.75 19.46
Support Level $4.62 N/A
Resistance Level $8.37 $1.27
Average True Range (ATR) 0.34 0.06
MACD 0.05 0.01
Stochastic Oscillator 72.29 2.70

Price Performance

Historical Comparison
AQMS
ANEB

About AQMS Aqua Metals Inc.

Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.

Share on Social Networks: